Toronto-based start-up lauded by World Economic Forum

World Economic Forum

It’s great to see that startup companies based in Toronto are making it to the world stage. In January 2007, at their prestigious annual meeting in Davos, Switzerland, the World Economic Forum will be announcing Amorfix Life Sciences Ltd. (Toronto) as one of 47 global companies chosen as a “Technology Pioneer”. It’s the only Canadian recipient in the list. In addition to this honour, Amorfix will also be featured in a bonus section of the December 11, 2007 issue of Time Magazine. The selection of Amorfix was based on their innovative diagnostic technologies for several brain-wasting diseases, including Alzheimer’s and Parkinson’s diseases, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig’s Disease) and variant Creutzfeldt-Jacob Disease (vCJD), also known as the human form of mad cow disease (Bovine Spongiform Encephalopathy or BSE).

The development for treatments for these diseases have been largely inhibited by the inability to directly measure the abnormal molecules that cause them. So Amorfix’s diagnostic technologies will significantly help accelerate the understanding of and development for treatments for these brain-wasting diseases. Congrats Amorfix!

Related Blogs

 

One step closer to better chemo for cancer
Congratulations to MaRS client RNA Diagnostics Inc., winners of the 2010 sanofi pasteur Healthcare and Biotechnology Venture Challenge (HBVC)! Rna Diagnostics’ product target is called RNA Disr

A bright future for diagnostic imaging in Ontario
Advances in diagnostic imaging are helping doctors and radiologists identify malignant tumours, cardiac issues and neurological diseases earlier and more accurately than ever before.  In many cases,

What role can physicians play in innovation?
Few physicians in the Discovery District would disagree with the assessment that their involvement in the commercialization of health technologies remains sparse, if not non-existent. They’re l

"I get to scrounge around the biggest candy store in the world – that is Science"
Renowned immunologist and cancer biologist Dr. Tak Mak got the discussion off to an enthusiastic start last week at MaRS when he characterized what it was that “got him out of bed in the morning�

Arctic is heating up
Life Sciences Ontario (LSO) has appointed long-time MaRS client ArcticDX the 2012 Emerging Life Sciences Company of the Year. ArcticDX is a molecular diagnostic company that is commercializing progno

Playing VC: Vote for the next Canadian innovator tackling global health
Looking to fellow Canadians for inspiration? Look no further. Grand Challenges Canada, an initiative helmed at the McLaughlin-Rotman Centre for Global Health (a MaRS Centre tenant!), aims to tackles

Tags: awards & competitions, canada, diagnostics, health care, life sciences, neuroscience, ontario